After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of Becton Dickinson & Co is $56.05B. A total of 2.38 million shares were traded on the day, compared to an average of 2.05M shares.
In the most recent transaction, Feld Michael sold 75 shares of BDX for 193.36 per share on Dec 01 ’25. After the transaction, the EVP, CRO & Pres. Life Sciences now owns 16,580 company shares. In a previous transaction on Dec 01 ’25, MICHAEL FELD bought 75 shares at 194.02 per share.
Among the insiders who sold shares, SCOTT BERTRAM L disposed of 217 shares on Nov 07 ’25 at a per-share price of $176.58. This resulted in the Director holding 35,816 shares of BDX after the transaction. In another insider transaction, BERTRAM SCOTT bought 217 shares at $176.58 per share on Nov 07 ’25.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Becton Dickinson & Co pays an annual dividend of $4.17, resulting in a dividend yield of 2.12%, and it has a price to earnings (P/E) ratio of 33.69.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BDX has a high of $251.99 and a low of $162.29.
As of this writing, BDX has an earnings estimate of $2.81 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $2.85 per share and a lower estimate of $2.79. The company reported an EPS of $3.43 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BDX’s latest balance sheet shows that the firm has $2.29B in Cash & Short Term Investments as of fiscal 2021. There were $17.61B in debt and $6.63B in liabilities at the time. Its Book Value Per Share was $88.96, while its Total Shareholder’s Equity was $23.68B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDX is Buy with a score of 3.67.
